COVID-19: the new challenge for rheumatologists

Clin Exp Rheumatol. 2020 Mar-Apr;38(2):175-180. doi: 10.55563/clinexprheumatol/r3k9l6. Epub 2020 Mar 24.

Authors

Francesco Ferro¹, Elena Elefante¹, Chiara Baldini¹, Elena Bartoloni², Ilaria Puxeddu³, Rosaria Talarico¹, Marta Mosca¹, Stefano Bombardieri⁴

Affiliations

¹ Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
² Rheumatology Unit, Department of Medicine, University of Perugia, Italy.
³ Clinical Immunology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.
⁴ University of Pisa, Italy. s.bombardieri@int.med.unipi.it.

PMID: 32207680
DOI: 10.55563/clinexprheumatol/r3k9l6

No abstract available

Publication types

Editorial
Comment

MeSH terms

Betacoronavirus*
COVID-19
Coronavirus Infections
Cytokines
Humans
Pandemics
Pneumonia, Viral
Rheumatologists*
SARS-CoV-2

Substances

Cytokines